Global Blood Pressure Transducers Market Is Estimated To Witness Significant Growth Owing To Growing Geriatric Population and Rising Incidences Of Cardiovascular Diseases

 

Blood Pressure Transducers

Overview:

Blood pressure transducers are devices that provide a catheter-to-monitor interface that enables intravascular and intracardiac pressure to be measured. These monitors are used to assess patient health status and diagnose various medical conditions. Bedside hemodynamic pressure monitoring is a vital tool in the management of critically ill patients. However, it requires adherence to proper techniques and safety precautions to ensure safe use. The demand for invasive blood pressure monitoring transducers is expected to grow significantly. This is attributed to the rising number of healthcare infrastructures, increasing prevalence of chronic diseases, and advancement in technology in the field of health care industry. Invasive blood pressure transducer system zeroing can be performed during initial setup or before insertion. It is a good idea to follow the manufacturer's recommendations for zeroing.

Market Dynamics:

Rising product launches by key players are estimated to augment growth of the global blood pressure transducers market during the forecast period. For instance, the Welch Allyn Spot Vital Signs 4400, was launched by Hillrom in February 2020. This is an easy-to-use next-generation vital signs device that is used for improving hypertension detection in emergency and ambulatory department settings. Moreover, rising costs associated with blood pressure monitoring transducers are anticipated to restrain growth of the global blood pressure transducers market during the forecast period.

Impact of COVID-19:

COVID-19 was first identified in 2019 and in 2020 it was declared as a global public health emergency by the World Health Organization. During the pandemic the number of COVID-19 cases were increasing on a daily basis. The pandemic affected the healthcare sector in an adverse manner. However, the pandemic had a positive impact on the blood pressure transducers market, as there was an increase in demand for transducers. Owing to growing awareness regarding blood pressure, rising incidence of hypertension, and the increasing geriatric population were all responsible for the increase in demand. Thus, during the pandemic the global blood pressure transducers market witnessed high growth.

Key Takeaways:

 

The global blood pressure transducers market is expected to witness robust growth, exhibiting CAGR of 6.22 % over the forecast period, due to rising acquisitions among key players. For instance, a cardiovascular technology company CardieX, acquired a California-based startup Blumio in November 2022. This acquisition will advance their vision to measure blood pressure accurately and easily and without relying on a cuff.

North America is anticipated to witness robust growth in the global blood pressure transducers market during the forecast period, due to growing incidence of hypertension and rising geriatric population.

Key players active in the global blood pressure transducers market are Biobeat, ADInstruments Pty Ltd., BIOPAC Systems Inc., Smiths Group Plc, Edwards Lifesciences Corp., A&D Medical Inc., GE Healthcare, Contec, Harvard Bioscience Inc., Microlife AG, ICU Medical Inc., Hill-Rom Services Inc., Koninklijke Philips NV, Omron Healthcare Welch Allyn, Inc., GF Health Products Inc., and SunTech Medical, Inc.